GNH USA

Europe — EMA

Minitran 5 (Glyceryl Trinitrate)

GNH USA supplies Minitran 5 (Glyceryl Trinitrate), a nitrate vasodilator for angina pectoris, providing rapid chest pain relief.

Request sourcing

1
Pack/s

What is Glyceryl Trinitrate?

Glyceryl Trinitrate, the active ingredient in Minitran 5, is a nitrate vasodilator presented as a transdermal patch for systemic use. It treats angina pectoris by reducing myocardial oxygen demand in patients with chronic stable angina.

GNH USA supplies Minitran 5 as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Glyceryl Trinitrate used for?

Glyceryl Trinitrate, a nitrate vasodilator, is indicated for conditions related to myocardial ischemia. - Angina pectoris: provides rapid relief of chest pain and reduces the frequency of attacks. - Chronic stable angina: helps prevent episodes of chest pain during exertion. - Acute angina episodes: delivers nitrate to alleviate sudden ischemic discomfort.

What are the side effects of Glyceryl Trinitrate?

Common Side Effects: - Headache: throbbing pain often occurring shortly after patch application. - Flushing: warmth and redness of the skin, especially on the face. - Dizziness: light‑headed sensation due to blood pressure reduction. - Hypotension: mild to moderate drop in blood pressure. - Tachycardia: compensatory increase in heart rate. - Skin irritation at the patch site: redness or itching.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to syncope. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare occurrence of heart attack. - Methemoglobinemia: abnormal hemoglobin causing reduced oxygen delivery. - Severe skin reactions: blistering or necrosis at the application site. - Allergic reactions: rash, swelling, or anaphylaxis.

What precautions apply to Glyceryl Trinitrate?

Before using Minitran 5, consider the following precautions: - Severe hypotension: avoid use in patients with markedly low blood pressure. - Phosphodiesterase‑5 inhibitors: do not combine with sildenafil or similar drugs due to risk of profound hypotension. - Blood pressure monitoring: check blood pressure regularly during therapy. - Patch site rotation: change application site to prevent local skin irritation. - Patient education: instruct on proper patch removal to reduce nitrate tolerance. - Store at room temperature: keep in original packaging, protect from moisture and light.

What does Glyceryl Trinitrate interact with?

Glyceryl trinitrate may interact with several medications.

Major Interactions (Avoid): - Sildenafil and other PDE5 inhibitors: can cause severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect may lead to dangerous blood pressure fall. - Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): may enhance blood pressure lowering.

Moderate Interactions (Monitor Closely): - Alcohol: may increase hypotensive effect. - Diuretics: can potentiate blood pressure reduction. - CYP3A4 inhibitors (e.g., erythromycin): may raise plasma nitrate levels.

Frequently asked questions

What is Minitran 5 used for?+
Minitran 5 is a transdermal patch that contains glyceryl trinitrate. It is indicated for the relief and prophylaxis of angina pectoris in patients with coronary artery disease, helping to reduce the frequency and severity of chest pain episodes.
How does glyceryl trinitrate work?+
Glyceryl trinitrate donates nitric oxide, which activates soluble guanylate cyclase in vascular smooth muscle. This raises cyclic GMP levels, causing relaxation of veins and arteries, lowering preload and afterload, and ultimately decreasing myocardial oxygen consumption.
What is the usual dose of Minitran 5?+
The prescribed dose is determined by the treating physician based on the patient’s clinical condition, severity of angina, and tolerance. Typically, one patch is applied for a specified number of hours per day with a drug‑free interval to avoid nitrate tolerance.
Is Minitran 5 safe in pregnancy or breastfeeding?+
Safety data are limited; the product is generally avoided during pregnancy and lactation unless the potential benefit outweighs the risk. Clinicians should carefully assess the risk‑benefit ratio and consider alternative therapies when appropriate.
How do I order Minitran 5 from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.
How does Minitran 5 compare with other anti‑anginal drugs?+
Compared with oral nitrates, the transdermal patch delivers more stable plasma concentrations and reduces dosing frequency, improving adherence. Unlike beta‑blockers or calcium‑channel blockers, it primarily reduces preload, but it can be combined with those agents for synergistic anti‑ischemic effects.
How should Minitran 5 be stored?+
Store the patch at room temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and children. Do not refrigerate or freeze the product.
How is Minitran 5 administered?+
Apply the patch to clean, dry, hair‑free skin on the chest, upper arm or back. Press firmly for several seconds to ensure adhesion. Replace the patch according to the prescribed schedule, usually after a drug‑free interval to minimise tolerance.
What are the most serious risks associated with Minitran 5?+
Serious adverse events include severe hypotension, syncope, myocardial infarction, methemoglobinemia, and life‑threatening skin reactions. Patients should be monitored for sudden drops in blood pressure, dizziness, or signs of an allergic response.
Who should not use Minitran 5?+
Contra‑indications include patients with severe hypotension, recent myocardial infarction, severe aortic stenosis, hypertrophic obstructive cardiomyopathy, or those taking phosphodiesterase‑5 inhibitors. It should also be avoided in individuals with known hypersensitivity to nitrates.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Glyceryl Trinitrate
Route
Cutaneous Use
Manufacturer
Mylan Healthcare B.V.
Origin
EU

Related products